References
- Simeon-Dubach D, Zeisberger S M, Hoerstrup S P. Quality Assurance in
Biobanking for Pre-Clinical Research. Transfus Med Hemother
2016;43(5):353-357.
- Yu K K, Zhang J, Li X, et al. Establishment and management of a lung
cancer biobank in Eastern China. Thoracic Cancer 2015;58–63.
- Fachiroh J, Dwianingsih E K, Wahdi A E, et al. Development of a
Biobank from a Legacy Collection in Universitas Gadjah Mada,
Indonesia: Proposed Approach for Centralized Biobank Development in
Low-Resource Institutions. Biopreserv Biobank 2019.
- Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5
million people: survey methods, baseline characteristics and long-term
follow-up. Int J Epidemiol 2011;40(6):1652-66.
- Trehearne A. Genetics, lifestyle and environment. UK Biobank is an
open access resource following the lives of 500,000 participants to
improve the health of future generations.
Bundesgesundheitsblatt
Gesundheitsforschung Gesundheitsschutz 2016;59(3):361-7.
- Holub P, Swertz M, Reihs R, et al. BBMRI-ERIC Directory: 515 Biobanks
with Over 60 Million Biological Samples. Biopreserv Biobank
2016;14(6):559-562.
- Porteri C, Pasqualetti P, Togni E, et al. Public’s attitudes on
participation in a biobank for research: an Italian survey. BMC
Medical Ethics 2014;15:81.
- Bourgeois F T, Avillach P, Kong S W, et al. Development of the
Precision Link Biobank at Boston Children’s Hospital: Challenges and
Opportunities. J Pers Med 2017;7(4).
- Zawati M H, Tassé A M, Mendy M, et al. Barriers and Opportunities in
Consent and Access Procedures in Low- and Middle-Income Country
Biobanks: Meeting Notes from the BCNet Training and General Assembly.
Biopreserv Biobank 2018;16(3):171-178.
- Quinlan P R, Mistry G, Bullbeck H, et al. A data standard for sourcing
fit-for-purpose biological samples in an integrated virtual network of
biobanks. Biopreserv Biobank 2014;12(3):184-91.
- Zhou Y T, Ge X T, Shen Y F, et al. Follow-up of the manganese-exposed
workers healthy cohort (MEWHC) and biobank management from 2011 to
2017 in China. BMC Public Health 2018;18:944.
- Draanen G V, Davidson P, Bour-Jordan H, et al. Assessing Researcher
Needs for a Virtual Biobank. Biopreserv Biobank 2017;15(3):203-210.
- Lacerda E M, Mudie K, Kingdon C C, et al. The UK ME/CFS Biobank: A
Disease-Specific Biobank for Advancing Clinical Research Into Myalgic
Encephalomyelitis/Chronic Fatigue Syndrome. Front Neurol 2018;9:1026.
- Henderson M K, Goldring K, Simeon-Dubach D, et al. Advancing
Professionalization of Biobank Business Operations: Performance and
Utilization. Biopreserv Biobank 2019;17(3):213-218.
- Hirata M, Kamatani Y, Nagai A, et al. Cross-sectional analysis of
BioBank Japan clinical data: A large cohort of 200,000 patients with
47 common diseases. J Epidemiol 2017;27(3S):S9-S21.
- Grizzle W E, Sexton K C, McGarvey D, et al. Lessons Learned During
Three Decades of Operations of Two Prospective Bioresources.
Biopreserv Biobank 2018;16(6):483-492.